STANDARD BIOTOOLS INC. — Director's Dealing 2023

Feb 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2023-02-21

Reporting Person: Davis Jeremy Steven (SVP Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-21	Common Stock	M	20833	—	Acquired	20833	Direct
2023-02-21	Common Stock	F	6176	$2.03	Disposed	14657	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-21	Restricted Stock Units	$	M	20833	Disposed		Common Stock (20833.0)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F2: On December 20, 2022, the Reporting Person was granted 250,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.